Residual tumor model in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy: Frequently involves the mucosa and/or submucosa

OBJECTIVES: The efficacy and safety of neoadjuvant immunochemotherapy (nICT) are widely explored in locally advanced esophageal squamous cell carcinoma (ESCC). Whether the “wait-and-see” strategy is applicable in ESCC after nICT is still lacking a theoretical basis. This study aimed to preliminarily...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lei, Hong, Zhi-Nuan, Wu, Long, Yang, Yinghong, Kang, Mingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780370/
https://www.ncbi.nlm.nih.gov/pubmed/36569913
http://dx.doi.org/10.3389/fimmu.2022.1008681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780370/
https://www.ncbi.nlm.nih.gov/pubmed/36569913
http://dx.doi.org/10.3389/fimmu.2022.1008681

Ejemplares similares